Growth hormoneDDTEXtREAd BoBo Bo5Bo$Bo%0Bo.Bo7Bo@rBowGROWTHORMONE **PhysiologyGH-RHromheypothalamustimulatesHecretion;omatostatininhibit(pituitaryׁreceptors:yp01,2,3,5). releasing8id8(syn8ticrhin)lsowoh[andGF-1xertegveeedbackntottenunsulsle,ithmpl defꊘgretight. 24ourw|maximalurzub(ydecfter20%Q191.a., 22D)ircunbound,majorieeBP1 (60؀20Pa)ۈiCed serum,~5>@ʃxthYϑ. PS/n844aIormasH꒑OctreoA (8Yawqana؍lohf-lifeItindshffinwof?orubs(V2 …7C~1pmin,omeIV`3s 45, 1113 mo8enta0ߖPB,lucago8insu speclyJZ)siwhichellrfac?,ulxgYdrizcruci0)ig@ransduh'generH(meÐproxxonsegrowQxon*!effxsOm@A`;2 = [A85%(m ,notcesylikޮ (thus,r1gJ0-5g/mL);by 7te,inlyBP-3QHburȪssayZ٤9А(itXp!XGHNĂdoha`dfangGciabubuϢa 15! 8nQlex9apoolqMalnishP8rhxctisۮ\ӚK (272pbr,)syste\heoblmhreٟanktweeeӮlKsia@dict7S (Pgue)߭**Ac((C@icfs PseudoaN:8(symm8ut(w(kAѰbyfj3ё0m @y5 RBCwarfZsHant):@agno)oelay`yearsТpidiouٌڥ5Ines 3-4ses/mill;yval 40-@;Sa)exQ`kIpituit!aȻ` (> 1m), sthorsscoρWީsEpriHclojb0piphyApuber +¡ɣ0;ig0ism齃gcdhood"Major9ѝ ȴؕдhcgearthgiaXwX2kSB!n2 GBl Fț0,tol,Pight砪s hyproXXSkx(dfeetougXjis(coHenXa}؃Xhidr{atig8,pzpigmHead/neck YachIgoirolsXpaЯenlargeQrogh,paw'!8iHAspa,oideepjincYoXn»occlusӍlXpneЉ0r@EyAVisuield`papede Car؛p myo-HF!rythmiaHTN;J,V@p1(`U D&libido t)dysfuBolig8f@ilcinephr`aIHh`(~70%/tspheos@8\һolyp@otrƧp2YcApbly) Neuro :bB@`Bptunneleiz EndGlu)DM (m equglycer3apoplexy MS Weakness,roximalyopathy,rthralgiaosteoporosiuitis Mortality 2-3orincromegaly;ntreated 8ientsave8verage 10eareduction!lifexpectancy. CardiovasculpdngemareeadingausefȄ81/3wqsignificant@aciseaseЇo: n(CAD &erebr&, 60%),spiratoryomplHAs (25 HA (1dabetesLotermmpactcolonicsZmhasteenstablished8Sleeppneaybstrٌ(2/3)r`Б(ossiblyueoysfunr(esom0xtinergwaysvolv8cool!bh)BstHdrmisurvivsHxvel. `Innousn0palsie8fo3musc,(Xialthe 6(mmepl08bi҈8ab2C: 99%Àbenituitaaden؃tuHcewMEN-1;xjoPsparsegЛY(SG"߀D؍C phȈ0am`MS));`Xdy opGHRHQ(Ԏst,tch,ung`ѣvȣdreXiӅeu)y;H (luphЊsueonejefPtislet-cellnon-Hodgkin'symph@_ciky؋Hccyhypysb7xMcCune-AlbrightyndYyerplXassopwi(mumemb؈8ouXGstein@4 8st £]yaycَiѭZcAMP)ZALrresSTggsyDGphsowlowٳinsi)0P[!ayoP}GJrapidlofto0Xve®zadul9ts\  10-↌iagnoɢn**Dɀ_X yٺ`dpulsXlePap,枠xubet,e ] ~ڳnor0olؽicth(npatut edGF-1A X'z< 2.5g/mLˁK (agge 0cp#):oodЮȽRexcepfw,tCreeH)muOJ; a烹𼉁u0!oorлl bslXDaireٽخϽHBbPiHo_(arg0GZAAn> 333C!ngsugg ^ Tbawx950davaluy< 1 OGTT؎Lsusp`gdolucitoleHcPop!sv@i@u8ypgung!75-100a`Hn,b8y¢P3012rۯؾ%(Tthroug@the鋘ssz൘donQolȀZRIA (qtwo-eRMAlŃ0.HC!F! 8cwipq?LW!Yta艀Ie((krhQ`q?erial,hichj1er), T}1waruff0.3-seemȒopбassayaExerc0mbI+,alse-pxYHi g,acomس /infarYiʙ(pkiუnp*BP-3,deshx$-iblYMotcromegaly,speciallynderreatment,GFBP-3aneormalithlevated!-1 (partfproductionsrive yz2,hichGH郸pent). declinesage; range2-4g/Ltay1aelpfulestPGHjHbor(rdolescs (highelsvpap,cic+ GHRHtimula8Not icsedueoYsubjects,uncomb`dinferipetrosinusampgloizpherxccultomatophiaȀ. Bug:TRa Pxqonsee up75%pr\alsodiabeelliturenandxrseaselaoutɎ{onain-raHg@onb@noȆw0IPobserv1csUsuppXsLodopaAm!agoni0adxHr,IcergHДesecrenSsnd0dict’ermL\aoȉapy0100cgocotidin1SC,Z0@n@llryPurH6-12rsn 2/3g@Жfir 9main8Ĥٔ6,CbegQP9e؄@ThȢbsolutePԦ@ldhecklaЌj40%avmixpita( b0јY~M*STST4,ƀIL corti0ul Xuri MRIyvisusmcibhiflDžAemptyllToIgnopHcynds:asuh+bdoPCT**T PrimgoX~Ae* (< 2.5g/mLт; < 1OGTT) }pss (showQm0ŷR!⹐GH/Nassoл)ҟleft triarssimey frOev om"tu@z)un"ssp@oidJrgc (95 %dll-beyٕrg) sw؀sofissHl u sensitivityndeductionningize. ItppearsoeellXlerated,utxperiencithhisgent HlimiX; 2at@tsave(dumorrowȄYonheicysfunꄀWpegvisomatreatmX,Hevels(cseqaose-dependner (dplHautweeks)ueydisceRlossfGF-1eedback,hichsnknowPmpliconsScr酈cRmostassays. Sele(agonisSSTR-2Z5 (ressemegaly-causAs), dopwihstronginhibit!sePthancotide2**GHormDeficQyIAdul`JClinplatu Preval~ 110,000 (3/T`luda{dgchildhoo set)2sxilyt`eeraituitarsComIJ`dio;の(> 90%)I@ inyurradiJ (usualHhypoismII)UnlurȟAr,OJDparti`GHRGcy)y`ft8pl(`|Kymptom8sign_"D:!System ManifК BodyBo RyextrllulvolumeXd柨m, (le0b(musclesAdi yH}c(,2cᝐssoczЅ8xmpailuc⨀xbet(mx Lipid0ofile HychXrmiHeخ NshZ.DL,po;HDL)hPhysBfymaximPoxy ptak@8htte;֣ eng,p5mobiy:m1Pb BMDiȯ\@obo xndicskxt9henogѢ7맪˜w.ƒ! (Wh4%s 8.7%nalstudy.ҲmbxxaxoXxJcoco8thyrare&AQɛfPMb or-be,帰gy, lemon⡂sexleeplf-Y! Carvas An 2-folc7 PtۺAbYobservK٨ (espeѯ0w0n);no؞ȶf8Iernt!-melckxP`prHc queɼД8eldysf(haP` ed S`Os@ sracutpu(Ѷ| fibrino &AI-1ڝic)LV'ѹQ(effecd(lop**Diagnh_shou@Xid8Gxalamic-disɩthwhohaتڶώYt(,ey25%n(O(70%,9C߱ 963+iea CXAlowGF( 'g뜑raɻ^li@5Z߈ښXtru_`)an10cHGdtGH猘b: 0.1/kgPء0sV (hig1[ 5*]LH(sua9׼;Y307adHfromOKCaukf8chcseizor lXOl (glycrnic`reghto@0p ظ1s).xMuxseeG < 40g/dlr(aP(,douexce18LXNǫH> 7g/mL;5[ (byIA, 2.IRMA񽠺sipeak-9inu(rA6)Ṱx<"Peop< 30typK310,eȹhat5 likeȺabs Qaș\is:udyXgg 1fhthITTIglucocoid!laceQ,!؛heayfhetimulatoryepngecausetannterfereithHesponse. PatientsBMI > 30aveecreasedsi:erve,9ulin 25%ailu@onTT;ishverseweightoss40%Ihypopituita8women.ȁgonadismrthyroiGFips M@8IGF-1HBP-3hnotHliablXndic15deficcyadHSlowHrmalangID. Orw!(EI> 5g/mLxceptsed): ginine (gVivoxmin,hibisom(stxsaf`,v(fPenx!epc 9);RH (1g/k,n& +|mo؎p8o̕peak9k,esspl(positsxh,seelushRH levodopa (500gO'BP < 1ѓBa> 60Óens+Ya/vom8[1l]clon Aaoodtagogu glucx1σgbP's**Tpt T@apssȚshowomprhodomSQ͞thssImuscNwaist-to-hipP)ht(by%)ndDLhoHolۄI,69li rin(a)]0Ncaؕ1na-mediacknX@ሡoXvor؀ypibrinogؑels:plasHac@Qityيإutalludi؃NVzsystol`fun8onO yshРdoi1ȒgrmuxinସsA#g hyplogqd(ntɲУ98ta0o/( diovascrQbpt런٧ɴhc $exerc8PrfncIbo`l؇y (uPyns۷orp> r)]fir3-6nthԨ`阅[Ђ] q2,(h%7BMDIobrd8)1ᕲd ,ll-bgqalifYTqGbPb 7tAcхAdhztriQ40R tQredubrinflam)rAגriskrkI(C-pXidIL-6HVr0H;LpXz"(g/d0cHgA1cIOʥidዑwama x&l1wځcd/`haXoɉز:paٶ4( (p28鲑SuggEЪ\:.ignif8nt? (a ̐뼀b.//(-1.D.a 2.5-folAIfrretwoe(cd "adGtfileWn лtPGFnٵthusrequi50%heh(makqonqlӴk (ouprBmpȳxl,~tsdPlr]*@s0C<{s٬8yab LXap;ᬐhchildrePퟡheir 20'ne200Cdv7whon 8CRael~oft limiѰs-effecd SqiSChjxieach n A{QiАd@om2y$FDA-omdy 3-ͳ±xikx25e.up35Jؾ 1HrI܋\GrowHؿ9R0arpSocie@ц'150ڏgRwet.gorٛ/lAmid@u򴘶sam(ex(D/uphalfѬ{3hadultnsetHDatientsaveowormalGF-1.osxfreatmPsstimatedt $5000/yr. Dosingegihsaryy er. Oneltarȃhes 300cg/d,e4nditrso g0aighr sideffectlerance Airqexpertah42k`usuallynou8achieha_ll*OHealthccUniversity: P Sqdose (noce8) Tiq4-6eeks Ehge Men 2 AdvI1^,ntili(oymptomg,hichhrom8fir 200-ϐWn)nsde8rogG P-orlj_pwSaq 68ߍw>፸60 1 5&iww(-hOTdayGHdminiXprobab)ymporta(circadianhsrel) viapen, frefrigA,zshelfifp0factorsnrugelXSs:ɒytudy, 37% opiph dX, 19%@thgi6%yl8%8rasthesias, 2%arp0tunnelndrS@hrel˝ycellularolupreplemresolx4Y8If(2-dexd#􀀨I}wix25؈h1redu R:1cluaggravPhy2headXbenignXi(gw( iabc`o@hyMoni ,bloodluc,HpJ0b!beefuS(s񵀐Iie薘HrapBul9Hs fq gly`yhemoglobi8bu(rin苁Xiiskprec҈ƍ!s؜}PCMxle((GH,",xhibi 11aHSDҭn<Ђ)3fpeivcoid-7thus !sCŸȗѷ8GHDha ϻtt0tri%9coutp8q/viscZp(loc.l1issue)⾄Əu tum 8ophngiomPaSurre:Hn@v`!thPro{ardiovascdis ljppsapchild0iurgirraʰ"hraxFrequsurveillZimagqhwuxalamIerm thadp'Kvء듪0eo@ **OZrowh AIDSаwdxnDA-rovJdicK@tHsHshow8X@bodsqd0fpY(@obse`ivHefitAd4abolnes9(e.g.rnpiIfailur@|)`9Pn*s( 滠y؈ coctg،itrogbh9?ateqXXr)ѥXICU:yQ(m100cg/kg/d)! 8oco talAd9`im߆۾xElxl1-(ha7zjGDdOs8if8hʺ)PngPexerch7AdvgdyceplwSt-mxminlenduythlKreffe3r alڻœgBhroninsufxYrԘher'PyndsmI(HArPta`**Refv1.) 1.eauscxF,ӉxssxPJietֻAcromegalyausedyecretionfrowthormoneaon-Hodgkin'symphoma. Nngl͂P2000;342:1871-6. 2.ookāXDiagnosisndherapyadultdeficiencyndxMTPȁouts, 82HAnnualng ؄docriSo8ty,up21-24,R:66-72(3.zzatӆA5otablinAm 1997;26:703-214.augansA,atesLׇreatmentmamhys5;52:207-13X5elmS`acksxI,leinbergĀiibkiCurrAguide foriJ󇧇P8;83:2646-56XonJdžGHw///////,2160`7.ewmanBYedicȓM9;28:1898.esmilo,illerMK,levadot,tlffectsonadministrasnnflammatorHoќrdiovasculariskarkers i0oDntern133:11 9halSMXGǟǑ@ϝ@H Pract108-11X10.akalaYRuokx,ebs8RInamortalit8ss`dOlj t8hs:341:785-9YPance,rasΈpۦchildǃGB1206-1 T0aboveeview ɧaЩ)Lpapl`refecحɥiveeftbe0mad`onsurcccxbutɒkearran(rتPerropmissی@umrespHibi liallos0ramagIsP1f(B@scontai8Fil_+rhouldIoriginex:.s(S#Gnp@ urpospd:(disdzcanPlmanom suggessM oodarzi.D0mg@net.ucla.edu @<**>@